E
KRTX

Ergoteles’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Ergoteles’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-29,476
Closed -$6.39M – 944
2023
Q2 		$6.39M Buy
29,476
+24,781
+528% +$5.31M 0.31% 81
2023
Q1 		$853K Sell
4,695
-10,762
-70% -$2.06M 0.03% 553
2022
Q4 		$3.04M Buy
+15,457
New +$3.31M 0.11% 186
2022
Q2 		– Sell
-8,381
Closed -$1.06M – 2095
2022
Q1 		$1.06M Sell
8,381
-2,565
-23% -$289K 0.04% 415
2021
Q4 		$1.43M Buy
+10,946
New +$1.41M 0.06% 332
2020
Q4 		– Sell
-3,885
Closed -$300K – 957
2020
Q3 		$300K Buy
+3,885
New +$331K 0.04% 346

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Ergoteles's KRTX Position: Q3 2023 in Review

Ergoteles sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2023, closing a stake of 29,476 shares — an estimated $6.39M sold.

Ergoteles first reported a position in KRTX in Q3 2020 and held it in 6 quarters. The position peaked at $6.39M in Q2 2023. 256 funds tracked by Wall St. Rank hold KRTX as of Q3 2023.

  • Ergoteles reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 29,476 Karuna Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $6.39M.
  • Ergoteles first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • Ergoteles's Karuna Therapeutics, Inc. Common Stock position peaked at $6.39M in Q2 2023.
  • 256 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.